SEC Company Response from FRESENIUS MEDICAL CARE CORP (CIK 0001019600) — Dec 30, 2005
FRESENIUS MEDICAL CARE CORP (CIK 0001019600)
Date: Dec. 30, 2005 · CIK: 0001019600 · Accession: 0000950123-05-015380
AI Filing Summary & Sentiment
File numbers found in text: 333-128899
Letter
Fresenius Medical Care AG
Else-Kröner Strasse 1
61352 Bad Homburg
Germany
December 30, 2005
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street N.E.
Washington, D.C. 20549
Attention: Jeffrey P. Riedler, Esq., Assistant Director
Re:
Fresenius Medical Care Aktiengesellschaft
Fresenius Medical Care AG & Co. KGaA
Registration Statement on Form F-4
Registration No. 333-128899
Gentlemen:
On behalf of each of the undersigned registrants, request is hereby made that the effective date of the above-captioned Registration Statement be accelerated so that it will become effective on January 4, 2006 at 10:00 A.M. Eastern Time, or as soon thereafter as may be practicable.
In connection with our submission of this request, we acknowledge that:
•
should the Securities and Exchange Commission (the “ Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the undersigned from their full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the undersigned companies may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Securities and Exchange Commission
December 30, 2006
Page 2
Very truly yours,
FRESENIUS MEDICAL CARE
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Fresenius Medical Care AG
Else-Kröner Strasse 1
61352 Bad Homburg
Germany
December 30, 2005
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street N.E.
Washington, D.C. 20549
Attention: Jeffrey P. Riedler, Esq., Assistant Director
Re:
Fresenius Medical Care Aktiengesellschaft
Fresenius Medical Care AG & Co. KGaA
Registration Statement on Form F-4
Registration No. 333-128899
Gentlemen:
On behalf of each of the undersigned registrants, request is hereby made that the effective
date of the above-captioned Registration Statement be accelerated so that it will become effective
on January 4, 2006 at 10:00 A.M. Eastern Time, or as soon thereafter as may be practicable.
In connection with our submission of this request, we acknowledge that:
•
should the Securities and Exchange Commission (the “ Commission”) or the staff,
acting pursuant to delegated authority, declare the filing effective, it does not
foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the undersigned
from their full responsibility for the adequacy and accuracy of the disclosure in
the filing; and
•
the undersigned companies may not assert staff
comments and the declaration of effectiveness as a defense
in any proceeding initiated by the Commission or any person
under the federal securities laws of the United
States.
Securities and Exchange Commission
December 30, 2006
Page 2
Very truly yours,
FRESENIUS MEDICAL CARE
AKTIENGESELLSCHAFT
By:
/s/ Ben Lipps
Dr. Ben Lipps
Chairman of the Management Board and
Authorized Representative in the United States
By:
/s/ Rainer Runte
Dr. Rainer Runte
Member of the Management Board
FRESENIUS MEDICAL CARE MANAGEMENT AG,
as general partner of Fresenius Medical Care AG & Co.
KGaA, a partnership limited by shares to be created
upon the transformation of legal form of Fresenius
Medical Care AG
By:
/s/ Lawrence Rosen
Lawrence Rosen
Member of the Management Board and
Authorized Representative in the United States